Savvy Updates 4/21/25: Dexcom 15-Day CGM Frequency of Failure, 39 States Push Legislation Against PBM-Pharmacy Ties, Beta Bionics iLet After 2 years, Walking & Heart Health, How Much Protein Do We Need, Vit. K Affects Brain Health, Huge Amounts of Diabetes-Related Waste, Abbott US Diabetes Sales Up 27%, Wearing Socks & Better Sleep
In this week’s issue of The Savvy Diabetic: Dexcom 15-Day CGM: 25% May Not Last for 15 Days 39 States Push Legislation Against PBM-Pharmacy Ties to Protect Competition Beta Bionics iLet After 2 years, with Stacey Simms Take a Brisk Walk for Heart Health...
Savvy Updates 4/14/25: DRI “Aggressively Working” on T1D Cure, Microbiome Therapy To Delay T1D Onset, Fully Closed AID Systems Effective, 025 Breakthroughs in D Research, D Distress Linked to Autonomic Symptoms, Medtech Industry Presses for Tariff Exemptions, Hearing & Heart Failure Risk, New Type of D 5, Heat & Kidney Transplant Recipients, Ex-FDA Chief Cites ‘Dysfunctional’ Congress, FTC Chair on PBM Insulin Case, Nursing Home Staffing Mandate Struck Down, Alcohol Changes Fat Levels
In this week’s issue of The Savvy Diabetic: Diabetes Research Institute (DRI) “Aggressively Working” on T1D Cure Microbiome Therapy To Delay T1D Onset Fully Closed AID Systems Effective Without Meal Announcements 2025 Breakthroughs in Diabetes...
Savvy Updates 4/7/25: Diabetes Treatment Breakthroughs, Saccharin Kills Multidrug-Resistant Bacteria, D & Bone Health, Avoiding Hypos During Exercise, GlucoSense App
In this week’s issue of The Savvy Diabetic: Diabetes Treatment Breakthroughs: Harmine to Stimulate Beta Cell Replication; Sana BioTechnology Islet Transplantation without Immunosuppression, AI-powered insulin delivery system Saccharin Kills...
Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay
Novo’s once-weekly insulin rejected by FDA by Kristin Jensen for BioPharmaDive.com, 11 July 2024. Novo is one of the world’s premier manufacturers, along with Indianapolis-based Eli Lilly. Both have been working for years to offer patients a more convenient option...
Savvy Updates 7/1/24: Senseonics 365-day CGM, Dana Lewis on Exocrine Pancreatic Insufficiency, Apple/Fitbit/Garmin & Bacteria, Low-Dose SGLT2 Inhibitor May Protect Kidneys, Dual GLP-1 & Glucagon Agonist Pemvidutide, How GLP-1 Receptor Agonists Work
Senseonics tips 365-day CGM to double 2025 sales by Nick Paul Taylor for MedTechDive.com, 25 June 2024. In 2024, Senseonics expects to more than double U.S. new patient starts and increase the global installed base by around 50%. The growth is built on the current...
More Diabetes Blogs